-
-
Recent Posts
Archives
Categories
-
Monthly Archives: November 2011
News: Breast Cancer: Basic and Clinical Research now on Intute
Libertas Academica is pleased to announce that Breast Cancer: Basic and Clinical Research is now added to Intute and journal content will be available there soon.Intute is a British based online resource that allows academics to search subj…
News: Articles Published During November 2011
These articles were published during the month of November 2011:Air, Soil and Water ResearchSyrian Water Resources between the Pres…
News: Forthcoming Articles For December 2011
These articles were announced as commencing production during the month of Novembe 2011:Air, Soil and Water ResearchOn the numerical study of indoor particle dispersion and spatial distributionBiomarke…
Interleukin-2 Works for Autoimmune Diseases (CME/CE)
(MedPage Today) — Low-dose interleukin-2 immunotherapy appears to be safe and effective in treating two immune-mediated diseases, two small, uncontrolled studies showed.
Tumor Sequencing Holds Promise for Trial Design (CME/CE)
(MedPage Today) — Genetic sequencing of clinical tumor samples can map the patient-specific mutational “landscape” to allow new types of biomarker-driven treatment trials, results of a pilot study suggested.
RSNA: Breast Cancer Rates Unaffected by Family History
CHICAGO (MedPage Today) — Women ages 40 to 49 with no family history of breast cancer have similar rates of invasive disease as those with familial risk, radiologist reported here, firing yet another salvo at government mammography guidelines.
Risk Factors Found for Sickle Cell Silent Strokes (CME/CE)
(MedPage Today) — Silent cerebral infarction is common for children with sickle cell anemia, but now researchers have identified risk factors associated with those silent strokes, according to a large cross-sectional study.
Close Watch May Be Enough After Molar Pregnancy (CME/CE)
(MedPage Today) — Most women whose human chorionic gonadotropin (hCG) was still elevated six months after uterine evacuation of a hydatidiform mole were able to avoid chemotherapy, researchers found.
New Article: Efficacy of Bevacizumab-Capecitabine in Combination for the First-Line Treatment of Metastatic Breast Cancer
There is an ongoing need for development of new chemotherapeutic regimens for metastatic breast cancer mBC, especially when tumors lack therapeutic targets such as the estrogen or progesterone receptor ER/PR, or the human epidermal growth factor …
A Little Nicotine Delivers Big Results (CME/CE)
(MedPage Today) — Significantly more smokers made a trial run of quitting when they received a brief course of nicotine therapy in addition to a behavioral intervention, results of a randomized trial showed.